1
|
Barboza M, Solakyildirim K, Knotts TA, Luke J, Gareau MG, Raybould HE, Lebrilla CB. Region-Specific Cell Membrane N-Glycome of Functional Mouse Brain Areas Revealed by nanoLC-MS Analysis. Mol Cell Proteomics 2021; 20:100130. [PMID: 34358619 PMCID: PMC8426282 DOI: 10.1016/j.mcpro.2021.100130] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 07/28/2021] [Accepted: 07/29/2021] [Indexed: 12/21/2022] Open
Abstract
N-glycosylation is a ubiquitous posttranslational modification that affects protein structure and function, including those of the central nervous system. N-glycans attached to cell membrane proteins play crucial roles in all aspects of biology, including embryogenesis, development, cell-cell recognition and adhesion, and cell signaling and communication. Although brain function and behavior are known to be regulated by the N-glycosylation state of numerous cell surface glycoproteins, our current understanding of brain glycosylation is limited, and glycan variations associated with functional brain regions remain largely unknown. In this work, we used a well-established cell surface glycomic nanoLC-Chip-Q-TOF platform developed in our laboratory to characterize the N-glycome of membrane fractions enriched in cell surface glycoproteins obtained from specific functional brain areas. We report the cell membrane N-glycome of two major developmental divisions of mice brain with specific and distinctive functions, namely the forebrain and hindbrain. Region-specific glycan maps were obtained with ∼120 N-glycan compositions in each region, revealing significant differences in "brain-type" glycans involving high mannose, bisecting, and core and antenna fucosylated species. Additionally, the cell membrane N-glycome of three functional regions of the forebrain and hindbrain, the cerebral cortex, hippocampus, and cerebellum, was characterized. In total, 125 N-glycan compositions were identified, and their region-specific expression profiles were characterized. Over 70 N-glycans contributed to the differentiation of the cerebral cortex, hippocampus, and cerebellum N-glycome, including bisecting and branched glycans with varying degrees of core and antenna fucosylation and sialylation. This study presents a comprehensive spatial distribution of the cell-membrane enriched N-glycomes associated with five discrete anatomical and functional brain areas, providing evidence for the presence of a previously unknown brain glyco-architecture. The region-specific molecular glyco fingerprints identified here will enable a better understanding of the critical biological roles that N-glycans play in the specialized functional brain areas in health and disease.
Collapse
Affiliation(s)
- Mariana Barboza
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California, USA; Department of Chemistry, University of California Davis, Davis, California, USA.
| | - Kemal Solakyildirim
- Department of Chemistry, University of California Davis, Davis, California, USA; Department of Chemistry, Erzincan Binali Yildirim University, Erzincan, Turkey
| | - Trina A Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, California, USA
| | - Jonathan Luke
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California, USA
| | - Melanie G Gareau
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California, USA
| | - Helen E Raybould
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California, USA
| | - Carlito B Lebrilla
- Department of Chemistry, University of California Davis, Davis, California, USA; Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California, USA
| |
Collapse
|
2
|
Keogh CE, Kim DHJ, Pusceddu MM, Knotts TA, Rabasa G, Sladek JA, Hsieh MT, Honeycutt M, Brust-Mascher I, Barboza M, Gareau MG. Myelin as a regulator of development of the microbiota-gut-brain axis. Brain Behav Immun 2021; 91:437-450. [PMID: 33157256 PMCID: PMC7749851 DOI: 10.1016/j.bbi.2020.11.001] [Citation(s) in RCA: 48] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 10/06/2020] [Accepted: 11/01/2020] [Indexed: 02/06/2023] Open
Abstract
Myelination in the peripheral and central nervous systems is critical in regulating motor, sensory, and cognitive functions. As myelination occurs rapidly during early life, neonatal gut dysbiosis during early colonization can potentially alter proper myelination by dysregulating immune responses and neuronal differentiation. Despite common usage of antibiotics (Abx) in children, the impact of neonatal Abx-induced dysbiosis on the development of microbiota, gut, brain (MGB) axis, including myelination and behavior, is unknown. We hypothesized that neonatal Abx-induced dysbiosis dysregulates host-microbe interactions, impairing myelination in the brain, and altering the MGB axis. Neonatal C57BL/6 mice were orally gavaged daily with an Abx cocktail (neomycin, vancomycin, ampicillin) or water (vehicle) from postnatal day 7 (P7) until weaning (P23) to induce gut dysbiosis. Behavior (cognition; anxiety-like behavior), microbiota sequencing, and qPCR (ileum, colon, hippocampus and pre-frontal cortex [PFC]) were performed in adult mice (6-8 weeks). Neonatal Abx administration led to intestinal dysbiosis in adulthood, impaired intestinal physiology, coupled with perturbations of bacterial metabolites and behavioral alterations (cognitive deficits and anxiolytic behavior). Expression of myelin-related genes (Mag, Mog, Mbp, Mobp, Plp) and transcription factors (Sox10, Myrf) important for oligodendrocytes were significantly increased in the PFC region of Abx-treated mice. Increased myelination was confirmed by immunofluorescence imaging and western blot analysis, demonstrating increased expression of MBP, SOX10 and MYRF in neonatally Abx-treated mice compared to sham controls in adulthood. Finally, administration of the short chain fatty acid butyrate following completion of the Abx treatment restored intestinal physiology, behavior, and myelination impairments, suggesting a critical role for the gut microbiota in mediating these effects. Taken together, we identified a long-lasting impact of neonatal Abx administration on the MGB axis, specifically on myelin regulation in the PFC region, potentially contributing to impaired cognitive function and bacterial metabolites are effective in reversing this altered phenotype.
Collapse
Affiliation(s)
- Ciara E Keogh
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Danielle H J Kim
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Matteo M Pusceddu
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Trina A Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Gonzalo Rabasa
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Jessica A Sladek
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Michael T Hsieh
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Mackenzie Honeycutt
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA; Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Ingrid Brust-Mascher
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Mariana Barboza
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
| | - Mélanie G Gareau
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
| |
Collapse
|
3
|
Lee S, Knotts TA, Goodson ML, Barboza M, Wudeck E, England G, Raybould HE. Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota. Nutrients 2020; 12:nu12113524. [PMID: 33207675 PMCID: PMC7696936 DOI: 10.3390/nu12113524] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 11/04/2020] [Accepted: 11/11/2020] [Indexed: 12/12/2022] Open
Abstract
The gut microbiota and associated metabolites have emerged as potential modulators of pathophysiological changes in obesity and related metabolic disorders. Butyrate, a product of bacterial fermentation, has been shown to have beneficial effects in obesity and rodent models of diet-induced obesity. Here, we aimed to determine the beneficial effects of butyrate (as glycerol ester of butyrate monobutyrin, MB) supplementation on metabolic phenotype, intestinal permeability and inflammation, feeding behavior, and the gut microbiota in low-fat (LF)- and high-fat (HF)-fed mice. Two cohorts (separated by 2 weeks) of male C57BL/6J mice (n = 24 in each cohort, 6/group/cohort; 6 weeks old) were separated into four weight-matched groups and fed either a LF (10 % fat/kcal) or HF (45% fat/kcal) with or without supplementation of MB (LF/MB or HF/MB) at 0.25% (w/v) in drinking water for 6 weeks. Metabolic phenotypes (body weight and adiposity), intestinal inflammation, feeding behavior, and fecal microbiome and metabolites were measured. Despite identical genetic and experimental conditions, we found marked differences between cohorts in the response (body weight gain, adiposity, and intestinal permeability) to HF-diet and MB. Notably, the composition of the gut microbiota was significantly different between cohorts, characterized by lower species richness and differential abundance of a large number of taxa, including subtaxa from five phyla, including increased abundance of the genera Bacteroides, Proteobacteria, and Parasutterella in cohort 2 compared to cohort 1. These differences may have contributed to the differential response in intestinal permeability to the HF diet in cohort 2. MB supplementation had no significant effect on metabolic phenotype, but there was a trend to protect from HF-induced impairments in intestinal barrier function in cohort 1 and in sensitivity to cholecystokinin (CCK) in both cohorts. These data support the concept that microbiota composition may have a crucial effect on metabolic responses of a host to dietary interventions and highlight the importance of taking steps to ensure reproducibility in rodent studies.
Collapse
Affiliation(s)
- Sunhye Lee
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
| | - Trina A. Knotts
- Department of Molecular Biosciences, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA;
| | - Michael L. Goodson
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
| | - Mariana Barboza
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
- Department of Chemistry, University of California Davis, Davis, CA 95616, USA
| | - Elyse Wudeck
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
| | - Grace England
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
| | - Helen E. Raybould
- Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA; (S.L.); (M.L.G.); (M.B.); (E.W.); (G.E.)
- Correspondence: ; Tel.: +1-530-754-6555
| |
Collapse
|
4
|
Goodson ML, Knotts TA, Campbell EL, Snyder CA, Young BM, Privalsky ML. Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism. PLoS One 2020; 15:e0241238. [PMID: 33104749 PMCID: PMC7588069 DOI: 10.1371/journal.pone.0241238] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Accepted: 10/10/2020] [Indexed: 12/15/2022] Open
Abstract
The NCoR corepressor plays critical roles in mediating transcriptional repression by both nuclear receptors and non-receptor transcription factors. Alternative mRNA splicing of NCoR produces a series of variants with differing molecular and biological properties. The NCoRω splice-variant inhibits adipogenesis whereas the NCoRδ splice-variant promotes it, and mice bearing a splice-specific knockout of NCoRω display enhanced hepatic steatosis and overall weight gain on a high fat diet as well as a greatly increased resistance to diet-induced glucose intolerance. We report here that the reciprocal NCoRδ splice-specific knock-out mice display the contrary phenotypes of reduced hepatic steatosis and reduced weight gain relative to the NCoRω-/- mice. The NCoRδ-/- mice also fail to demonstrate the strong resistance to diet-induced glucose intolerance exhibited by the NCoRω-/- animals. The NCoR δ and ω variants possess both unique and shared transcriptional targets, with expression of certain hepatic genes affected in opposite directions in the two mutants, others altered in one but not the other genotype, and yet others changed in parallel in both NCoRδ-/- and NCoRω-/- animals versus WT. Gene set expression analysis (GSEA) identified a series of lipid, carbohydrate, and amino acid metabolic pathways that are likely to contribute to their distinct steatosis and glucose tolerance phenotypes. We conclude that alternative-splicing of the NCoR corepressor plays a key role in the regulation of hepatic energy storage and utilization, with the NCoRδ and NCoRω variants exerting both opposing and shared functions in many aspects of this phenomenon and in the organism as a whole.
Collapse
Affiliation(s)
- Michael L. Goodson
- Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America
- * E-mail:
| | - Trina A. Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine and Mouse Metabolic Phenotyping Center, Microbiome & Host Response Core, University of California at Davis, Davis, California, United States of America
| | - Elsie L. Campbell
- Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America
| | - Chelsea A. Snyder
- Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America
| | - Briana M. Young
- Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America
| | - Martin L. Privalsky
- Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America
| |
Collapse
|
5
|
Salvo E, Stokes P, Keogh CE, Brust-Mascher I, Hennessey C, Knotts TA, Sladek JA, Rude KM, Swedek M, Rabasa G, Gareau MG. A murine model of pediatric inflammatory bowel disease causes microbiota-gut-brain axis deficits in adulthood. Am J Physiol Gastrointest Liver Physiol 2020; 319:G361-G374. [PMID: 32726162 PMCID: PMC7509259 DOI: 10.1152/ajpgi.00177.2020] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Inflammatory bowel diseases (IBDs) are chronic intestinal diseases, frequently associated with comorbid psychological and cognitive deficits. These neuropsychiatric effects include anxiety, depression, and memory impairments that can be seen both during active disease and following remission and are more frequently seen in pediatric patients. The mechanism(s) through which these extraintestinal deficits develop remain unknown, and the study of these phenomenon is hampered by a lack of murine pediatric IBD models. Herein we describe microbiota-gut-brain (MGB) axis deficits following induction of colitis in a pediatric setting. Acute colitis was induced by administration of 2% dextran sodium sulfate (DSS) for 5 days starting at weaning [postnatal day (P)21] causing reduced weight gain, colonic shortening, and colonic inflammation by 8 days post-DSS (P29), which were mostly resolved in adult (P56) mice. Despite resolution of acute disease, cognitive deficits (novel object recognition task) and anxiety-like behavior (light/dark box) were identified in the absence of changes in exploratory behavior (open field test) in P56 mice previously treated with DSS at weaning. Behavioral deficits were found in conjunction with neuroinflammation, decreased neurogenesis, and altered expression of pattern recognition receptor genes in the hippocampus. Additionally, persistent alterations in the gut microbiota composition were observed at P56, including reduced butyrate-producing species. Taken together, these results describe for the first time the presence of MGB axis deficits following induction of colitis at weaning, which persist in adulthood.NEW & NOTEWORTHY Here we describe long-lasting impacts on the microbiota-gut-brain (MGB) axis following administration of low-dose dextran sodium sulfate (DSS) to weaning mice (P21), including gut dysbiosis, colonic inflammation, and brain/behavioral deficits in adulthood (P56). Early-life DSS leads to acute colonic inflammation, similar to adult mice; however, it results in long-lasting deficits in the MGB axis in adulthood (P56), in contrast to the transient deficits seen in adult DSS. This model highlights the unique features of pediatric inflammatory bowel disease.
Collapse
Affiliation(s)
- Eloisa Salvo
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Patricia Stokes
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Ciara E. Keogh
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Ingrid Brust-Mascher
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Carly Hennessey
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Trina A. Knotts
- 2Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California
| | - Jessica A. Sladek
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Kavi M. Rude
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Michelle Swedek
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Gonzalo Rabasa
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| | - Mélanie G. Gareau
- 1Department of Anatomy, Physiology and Cell Biology, University of California, Davis, California
| |
Collapse
|
6
|
Rutkowsky JM, Knotts TA, Allen PD, Pessah IN, Ramsey JJ. Sex-specific alterations in whole body energetics and voluntary activity in heterozygous R163C malignant hyperthermia-susceptible mice. FASEB J 2020; 34:8721-8733. [PMID: 32367593 PMCID: PMC7383697 DOI: 10.1096/fj.202000403] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 04/20/2020] [Indexed: 11/20/2022]
Abstract
Malignant hyperthermia (MH) is characterized by induction of skeletal muscle hyperthermia in response to a dysregulated increase in myoplasmic calcium. Although altered energetics play a central role in MH, MH‐susceptible humans and mouse models are often described as having no phenotype until exposure to a triggering agent. The purpose of this study was to determine the influence of the R163C ryanodine receptor 1 mutation, a common MH mutation in humans, on energy expenditure, and voluntary wheel running in mice. Energy expenditure was measured by indirect respiration calorimetry in wild‐type (WT) and heterozygous R163C (HET) mice over a range of ambient temperatures. Energy expenditure adjusted for body weight or lean mass was increased (P < .05) in male, but not female, HET mice housed at 22°C or when housed at 28°C with a running wheel. In female mice, voluntary wheel running was decreased (P < .05) in the HET vs WT animals when analyzed across ambient temperatures. The thermoneutral zone was also widened in both male and female HET mice. The results of the study show that the R163C mutations alters energetics even at temperatures that do not typically induce MH.
Collapse
Affiliation(s)
- Jennifer M Rutkowsky
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Trina A Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Paul D Allen
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Isaac N Pessah
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Jon J Ramsey
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| |
Collapse
|
7
|
McCoin CS, Gillingham MB, Knotts TA, Vockley J, Ono-Moore KD, Blackburn ML, Norman JE, Adams SH. Blood cytokine patterns suggest a modest inflammation phenotype in subjects with long-chain fatty acid oxidation disorders. Physiol Rep 2020; 7:e14037. [PMID: 30912279 PMCID: PMC6434073 DOI: 10.14814/phy2.14037] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 03/04/2019] [Accepted: 03/05/2019] [Indexed: 12/17/2022] Open
Abstract
Excessive cellular accumulation or exposure to lipids such as long‐chain acylcarnitines (LCACs), ceramides, and others is implicated in cell stress and inflammation. Such a situation might manifest when there is a significant mismatch between long‐chain fatty acid (LCFA) availability versus storage and oxidative utilization; for example, in cardiac ischemia, increased LCACs may contribute to tissue cell stress and infarct damage. Perturbed LCFAβ‐oxidation is also seen in fatty acid oxidation disorders (FAODs). FAODs typically manifest with fasting‐ or stress‐induced symptoms, and patients can manage many symptoms through control of diet and physical activity. However, episodic clinical events involving cardiac and skeletal muscle myopathies are common and can present without an obvious molecular trigger. We have speculated that systemic or tissue‐specific lipotoxicity and activation of inflammation pathways contribute to long‐chain FAOD pathophysiology. With this in mind, we characterized inflammatory phenotype (14 blood plasma cytokines) in resting, overnight‐fasted (~10 h), or exercise‐challenged subjects with clinically well‐controlled long‐chain FAODs (n = 12; 10 long‐chain 3‐hydroxyacyl‐CoA dehydrogenase [LCHAD]; 2 carnitine palmitoyltransferase 2 [CPT2]) compared to healthy controls (n = 12). Across experimental conditions, concentrations of three cytokines were modestly but significantly increased in FAOD (IFNγ, IL‐8, and MDC), and plasma levels of IL‐10 (considered an inflammation‐dampening cytokine) were significantly decreased. These novel results indicate that while asymptomatic FAOD patients do not display gross body‐wide inflammation even after moderate exercise, β‐oxidation deficiencies might be associated with chronic and subtle activation of “sterile inflammation.” Further studies are warranted to determine if inflammation is more apparent in poorly controlled long‐chain FAOD or when long‐chain FAOD‐associated symptoms are present.
Collapse
Affiliation(s)
- Colin S McCoin
- Department of Molecular and Integrative Physiology, Medical Center, University of Kansas, Kansas City, Kansas
| | - Melanie B Gillingham
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon
| | - Trina A Knotts
- School of Medicine Department of Anatomy, Physiology and Cell Biology, University of California, Davis, School of Veterinary Medicine, Davis, California
| | - Jerry Vockley
- Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania
| | | | - Michael L Blackburn
- Arkansas Children's Nutrition Center, Little Rock, Arkansas.,Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Jennifer E Norman
- Department of Internal Medicine, University of California, Davis, School of Medicine, Davis, California
| | - Sean H Adams
- Arkansas Children's Nutrition Center, Little Rock, Arkansas.,Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| |
Collapse
|
8
|
Vogel Ciernia A, Yasui DH, Pride MC, Durbin-Johnson B, Noronha AB, Chang A, Knotts TA, Rutkowsky JR, Ramsey JJ, Crawley JN, LaSalle JM. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome. Hum Mol Genet 2018; 27:4077-4093. [PMID: 30137367 PMCID: PMC6240741 DOI: 10.1093/hmg/ddy301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Revised: 08/10/2018] [Accepted: 08/14/2018] [Indexed: 01/27/2023] Open
Abstract
Mutations in the X-linked gene MECP2 cause the majority of Rett syndrome (RTT) cases. Two differentially spliced isoforms of exons 1 and 2 (MeCP2-e1 and MeCP2-e2) contribute to the diverse functions of MeCP2, but only mutations in exon 1, not exon 2, are observed in RTT. We previously described an isoform-specific MeCP2-e1-deficient male mouse model of a human RTT mutation that lacks MeCP2-e1 while preserving expression of MeCP2-e2. However, RTT patients are heterozygous females that exhibit delayed and progressive symptom onset beginning in late infancy, including neurologic as well as metabolic, immune, respiratory and gastrointestinal phenotypes. Consequently, we conducted a longitudinal assessment of symptom development in MeCP2-e1 mutant females and males. A delayed and progressive onset of motor impairments was observed in both female and male MeCP2-e1 mutant mice, including hind limb clasping and motor deficits in gait and balance. Because these motor impairments were significantly impacted by age-dependent increases in body weight, we also investigated metabolic phenotypes at an early stage of disease progression. Both male and female MeCP2-e1 mutants exhibited significantly increased body fat compared to sex-matched wild-type littermates prior to weight differences. Mecp2e1-/y males exhibited significant metabolic phenotypes of hypoactivity, decreased energy expenditure, increased respiratory exchange ratio, but decreased food intake compared to wild-type. Untargeted analysis of lipid metabolites demonstrated a distinguishable profile in MeCP2-e1 female mutant liver characterized by increased triglycerides. Together, these results demonstrate that MeCP2-e1 mutation in mice of both sexes recapitulates early and progressive metabolic and motor phenotypes of human RTT.
Collapse
Affiliation(s)
- Annie Vogel Ciernia
- Department of Medical Microbiology and Immunology, UC Davis School of Medicine, University of California, Davis, CA, USA
- UC Davis Genome Center, University of California, Davis, CA, USA
- UC Davis MIND Institute, University of California, Davis, CA, USA
| | - Dag H Yasui
- Department of Medical Microbiology and Immunology, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Michael C Pride
- UC Davis MIND Institute, University of California, Davis, CA, USA
- Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Blythe Durbin-Johnson
- Department of Public Health Sciences, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Adriana B Noronha
- Department of Medical Microbiology and Immunology, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Alene Chang
- Department of Medical Microbiology and Immunology, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Trina A Knotts
- Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Jennifer R Rutkowsky
- Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Jon J Ramsey
- Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Jacqueline N Crawley
- UC Davis MIND Institute, University of California, Davis, CA, USA
- Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine, University of California, Davis, CA, USA
| | - Janine M LaSalle
- Department of Medical Microbiology and Immunology, UC Davis School of Medicine, University of California, Davis, CA, USA
- UC Davis Genome Center, University of California, Davis, CA, USA
- UC Davis MIND Institute, University of California, Davis, CA, USA
| |
Collapse
|
9
|
Allan N, Knotts TA, Pesapane R, Ramsey JJ, Castle S, Clifford D, Foley J. Conservation Implications of Shifting Gut Microbiomes in Captive-Reared Endangered Voles Intended for Reintroduction into the Wild. Microorganisms 2018; 6:microorganisms6030094. [PMID: 30213049 PMCID: PMC6165168 DOI: 10.3390/microorganisms6030094] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2018] [Revised: 09/05/2018] [Accepted: 09/11/2018] [Indexed: 12/16/2022] Open
Abstract
The Amargosa vole is a highly endangered rodent endemic to a small stretch of the Amargosa River basin in Inyo County, California. It specializes on a single, nutritionally marginal food source in nature. As part of a conservation effort to preserve the species, a captive breeding population was established to serve as an insurance colony and a source of individuals to release into the wild as restored habitat becomes available. The colony has successfully been maintained on commercial diets for multiple generations, but there are concerns that colony animals could lose gut microbes necessary to digest a wild diet. We analyzed feces from colony-reared and recently captured wild-born voles on various diets, and foregut contents from colony and wild voles. Unexpectedly, fecal microbial composition did not greatly differ despite drastically different diets and differences observed were mostly in low-abundance microbes. In contrast, colony vole foregut microbiomes were dominated by Allobaculum sp. while wild foreguts were dominated by Lactobacillus sp. If these bacterial community differences result in beneficial functional differences in digestion, then captive-reared Amargosa voles should be prepared prior to release into the wild to minimize or eliminate those differences to maximize their chance of success.
Collapse
Affiliation(s)
- Nora Allan
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
- Wildlife Investigations Lab, California Department of Fish and Wildlife, 1701 Nimbus Road, Rancho Cordova, CA 95670, USA.
| | - Trina A Knotts
- Department of Molecular Biosciences, University of California, Davis, CA 95616, USA.
| | - Risa Pesapane
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
| | - Jon J Ramsey
- Department of Molecular Biosciences, University of California, Davis, CA 95616, USA.
| | - Stephanie Castle
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
- Wildlife Investigations Lab, California Department of Fish and Wildlife, 1701 Nimbus Road, Rancho Cordova, CA 95670, USA.
| | - Deana Clifford
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
- Wildlife Investigations Lab, California Department of Fish and Wildlife, 1701 Nimbus Road, Rancho Cordova, CA 95670, USA.
| | - Janet Foley
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
| |
Collapse
|
10
|
Rutkowsky JM, Lee LL, Puchowicz M, Golub MS, Befroy DE, Wilson DW, Anderson S, Cline G, Bini J, Borkowski K, Knotts TA, Rutledge JC. Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet. PLoS One 2018; 13:e0191909. [PMID: 29444171 PMCID: PMC5812615 DOI: 10.1371/journal.pone.0191909] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Accepted: 01/12/2018] [Indexed: 12/20/2022] Open
Abstract
Recent work suggests that diet affects brain metabolism thereby impacting cognitive function. Our objective was to determine if a western diet altered brain metabolism, increased blood-brain barrier (BBB) transport and inflammation, and induced cognitive impairment in C57BL/6 (WT) mice and low-density lipoprotein receptor null (LDLr -/-) mice, a model of hyperlipidemia and cognitive decline. We show that a western diet and LDLr -/- moderately influence cognitive processes as assessed by Y-maze and radial arm water maze. Also, western diet significantly increased BBB transport, as well as microvessel factor VIII in LDLr -/- and microglia IBA1 staining in WT, both indicators of activation and neuroinflammation. Interestingly, LDLr -/- mice had a significant increase in 18F- fluorodeoxyglucose uptake irrespective of diet and brain 1H-magnetic resonance spectroscopy showed increased lactate and lipid moieties. Metabolic assessments of whole mouse brain by GC/MS and LC/MS/MS showed that a western diet altered brain TCA cycle and β-oxidation intermediates, levels of amino acids, and complex lipid levels and elevated proinflammatory lipid mediators. Our study reveals that the western diet has multiple impacts on brain metabolism, physiology, and altered cognitive function that likely manifest via multiple cellular pathways.
Collapse
Affiliation(s)
- Jennifer M. Rutkowsky
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California, United States of America
- * E-mail:
| | - Linda L. Lee
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis, California, United States of America
| | - Michelle Puchowicz
- Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America
| | - Mari S. Golub
- Department of Environmental Toxicology, University of California, Davis, California, United States of America
| | - Douglas E. Befroy
- Magnetic Resonance Research Center, Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut, United States of America
| | - Dennis W. Wilson
- Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, California, United States of America
| | - Steven Anderson
- Department of Physiology and Membrane Biology, University of California, Davis, California, United States of America
| | - Gary Cline
- Department of Endocrinology, Yale University, New Haven, Connecticut, United States of America
| | - Jason Bini
- Yale PET Center, Department of Diagnostic Radiology, Yale University, New Haven, Connecticut, United States of America
| | - Kamil Borkowski
- West Coast Metabolomics Center, Genome Center, University of California, Davis, California, United States of America
| | - Trina A. Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California, United States of America
| | - John C. Rutledge
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California, United States of America
| | | |
Collapse
|
11
|
McCoin CS, Piccolo BD, Knotts TA, Matern D, Vockley J, Gillingham MB, Adams SH. Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation. J Inherit Metab Dis 2016; 39:399-408. [PMID: 26907176 PMCID: PMC4851894 DOI: 10.1007/s10545-016-9915-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 01/09/2016] [Accepted: 01/22/2016] [Indexed: 01/29/2023]
Abstract
Blood and urine acylcarnitine profiles are commonly used to diagnose long-chain fatty acid oxidation disorders (FAOD: i.e., long-chain hydroxy-acyl-CoA dehydrogenase [LCHAD] and carnitine palmitoyltransferase 2 [CPT2] deficiency), but the global metabolic impact of long-chain FAOD has not been reported. We utilized untargeted metabolomics to characterize plasma metabolites in 12 overnight-fasted individuals with FAOD (10 LCHAD, two CPT2) and 11 healthy age-, sex-, and body mass index (BMI)-matched controls, with the caveat that individuals with FAOD consume a low-fat diet supplemented with medium-chain triglycerides (MCT) while matched controls consume a typical American diet. In plasma 832 metabolites were identified, and partial least squared-discriminant analysis (PLS-DA) identified 114 non-acylcarnitine variables that discriminated FAOD subjects and controls. FAOD individuals had significantly higher triglycerides and lower specific phosphatidylethanolamines, ceramides, and sphingomyelins. Differences in phosphatidylcholines were also found but the directionality differed by metabolite species. Further, there were few differences in non-lipid metabolites, indicating the metabolic impact of FAOD specifically on lipid pathways. This analysis provides evidence that LCHAD/CPT2 deficiency significantly alters complex lipid pathway flux. This metabolic signature may provide new clinical tools capable of confirming or diagnosing FAOD, even in subjects with a mild phenotype, and may provide clues regarding the biochemical and metabolic impact of FAOD that is relevant to the etiology of FAOD symptoms.
Collapse
Affiliation(s)
- Colin S McCoin
- Molecular, Cellular and Integrative Physiology Graduate Group, University of California, Davis, CA, USA
| | - Brian D Piccolo
- Arkansas Children's Nutrition Center and Department of Pediatrics, University of Arkansas for Medical Sciences, 15 Children's Way, Little Rock, AR, 72202, USA
| | - Trina A Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA
| | - Dietrich Matern
- Biochemical Genetics Laboratory, Mayo Clinic, Rochester, MN, USA
| | - Jerry Vockley
- Department of Pediatrics, School of Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
- Department of Human Genetics, Graduate School of Public Health, Pittsburgh, PA, USA
| | - Melanie B Gillingham
- Department of Molecular & Medical Genetics and Graduate Programs in Human Nutrition, Oregon Health & Science University, Portland, OR, USA
| | - Sean H Adams
- Molecular, Cellular and Integrative Physiology Graduate Group, University of California, Davis, CA, USA.
- Arkansas Children's Nutrition Center and Department of Pediatrics, University of Arkansas for Medical Sciences, 15 Children's Way, Little Rock, AR, 72202, USA.
| |
Collapse
|
12
|
Abstract
Perturbations in metabolic pathways can cause substantial increases in plasma and tissue concentrations of long-chain acylcarnitines (LCACs). For example, the levels of LCACs and other acylcarnitines rise in the blood and muscle during exercise, as changes in tissue pools of acyl-coenzyme A reflect accelerated fuel flux that is incompletely coupled to mitochondrial energy demand and capacity of the tricarboxylic acid cycle. This natural ebb and flow of acylcarnitine generation and accumulation contrasts with that of inherited fatty acid oxidation disorders (FAODs), cardiac ischaemia or type 2 diabetes mellitus. These conditions are characterized by very high (FAODs, ischaemia) or modestly increased (type 2 diabetes mellitus) tissue and blood levels of LCACs. Although specific plasma concentrations of LCACs and chain-lengths are widely used as diagnostic markers of FAODs, research into the potential effects of excessive LCAC accumulation or the roles of acylcarnitines as physiological modulators of cell metabolism is lacking. Nevertheless, a growing body of evidence has highlighted possible effects of LCACs on disparate aspects of pathophysiology, such as cardiac ischaemia outcomes, insulin sensitivity and inflammation. This Review, therefore, aims to provide a theoretical framework for the potential consequences of tissue build-up of LCACs among individuals with metabolic disorders.
Collapse
Affiliation(s)
- Colin S McCoin
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
| | - Trina A Knotts
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - Sean H Adams
- Arkansas Children's Nutrition Center and Department of Pediatrics, University of Arkansas for Medical Sciences, 15 Children's Way, Little Rock, AR 72202, USA
| |
Collapse
|
13
|
McCoin CS, Knotts TA, Ono-Moore KD, Oort PJ, Adams SH. Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects. Am J Physiol Endocrinol Metab 2015; 308:E990-E1000. [PMID: 25852008 PMCID: PMC4451287 DOI: 10.1152/ajpendo.00602.2014] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Accepted: 04/06/2015] [Indexed: 01/08/2023]
Abstract
Acylcarnitines, important lipid biomarkers reflective of acyl-CoA status, are metabolites that possess bioactive and inflammatory properties. This study examined the potential for long-chain acylcarnitines to activate cellular inflammatory, stress, and death pathways in a skeletal muscle model. Differentiated C2C12 myotubes treated with l-C14, C16, C18, and C18:1 carnitine displayed dose-dependent increases in IL-6 production with a concomitant rise in markers of cell permeability and death, which was not observed for shorter chain lengths. l-C16 carnitine, used as a representative long-chain acylcarnitine at initial extracellular concentrations ≥25 μM, increased IL-6 production 4.1-, 14.9-, and 31.4-fold over vehicle at 25, 50, and 100 μM. Additionally, l-C16 carnitine activated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase between 2.5- and 11-fold and induced cell injury and death within 6 h with modest activation of the apoptotic caspase-3 protein. l-C16 carnitine rapidly increased intracellular calcium, most clearly by 10 μM, implicating calcium as a potential mechanism for some activities of long-chain acylcarnitines. The intracellular calcium chelator BAPTA-AM blunted l-C16 carnitine-mediated IL-6 production by >65%. However, BAPTA-AM did not attenuate cell permeability and death responses, indicating that these outcomes are calcium independent. The 16-carbon zwitterionic compound amidosulfobetaine-16 qualitatively mimicked the l-C16 carnitine-associated cell stress outcomes, suggesting that the effects of high experimental concentrations of long-chain acylcarnitines are through membrane disruption. Herein, a model is proposed in which acylcarnitine cell membrane interactions take place along a spectrum of cellular concentrations encountered in physiological-to-pathophysiological conditions, thus regulating function of membrane-based systems and impacting cell biology.
Collapse
Affiliation(s)
- Colin S McCoin
- Molecular, Cellular and Integrative Physiology Graduate Group, University of California, Davis, California
| | - Trina A Knotts
- Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, CA; Department of Nutrition, University of California, Davis, Davis, California; and
| | - Kikumi D Ono-Moore
- Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, CA
| | - Pieter J Oort
- Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, CA
| | - Sean H Adams
- Molecular, Cellular and Integrative Physiology Graduate Group, University of California, Davis, California; Department of Nutrition, University of California, Davis, Davis, California; and Arkansas Children's Nutrition Center and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| |
Collapse
|
14
|
Piccolo BD, Comerford KB, Karakas SE, Knotts TA, Fiehn O, Adams SH. Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial. J Nutr 2015; 145:691-700. [PMID: 25833773 DOI: 10.3945/jn.114.203943] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2014] [Accepted: 12/29/2014] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND It has been suggested that perturbations in branched-chain amino acid (BCAA) catabolism are associated with insulin resistance and contribute to elevated systemic BCAAs. Evidence in rodents suggests dietary protein rich in BCAAs can increase BCAA catabolism, but there is limited evidence in humans. OBJECTIVE We hypothesize that a diet rich in BCAAs will increase BCAA catabolism, which will manifest in a reduction of fasting plasma BCAA concentrations. METHODS The metabolome of 27 obese women with metabolic syndrome before and after weight loss was investigated to identify changes in BCAA metabolism using GC-time-of-flight mass spectrometry. Subjects were enrolled in an 8-wk weight-loss study including either a 20-g/d whey (whey group, n = 16) or gelatin (gelatin group, n = 11) protein supplement. When matched for total protein by weight, whey protein has 3 times the amount of BCAAs compared with gelatin protein. RESULTS Postintervention plasma abundances of Ile (gelatin group: 637 ± 18, quantifier ion peak height ÷ 100; whey group: 744 ± 65), Leu (gelatin group: 1210 ± 33; whey group: 1380 ± 79), and Val (gelatin group: 2080 ± 59; whey group: 2510 ± 230) did not differ between treatment groups. BCAAs were significantly correlated with homeostasis model assessment of insulin resistance at baseline (r = 0.52, 0.43, and 0.49 for Leu, Ile, and Val, respectively; all, P < 0.05), but correlations were no longer significant at postintervention. Pro- and Cys-related pathways were found discriminant of whey protein vs. gelatin protein supplementation in multivariate statistical analyses. CONCLUSIONS These findings suggest that BCAA metabolism is, at best, only modestly affected at a whey protein supplementation dose of 20 g/d. Furthermore, the loss of an association between postintervention BCAA and homeostasis model assessment suggests that factors associated with calorie restriction or protein intake affect how plasma BCAAs relate to insulin sensitivity. This trial was registered at clinicaltrials.gov as NCT00739479.
Collapse
Affiliation(s)
- Brian D Piccolo
- Obesity and Metabolism Research Unit, USDA, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA
| | - Kevin B Comerford
- Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The University of California Davis Medical Center, Sacramento, CA; and Department of Nutrition
| | - Sidika E Karakas
- Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The University of California Davis Medical Center, Sacramento, CA; and
| | - Trina A Knotts
- Obesity and Metabolism Research Unit, USDA, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA; Department of Nutrition
| | - Oliver Fiehn
- West Coast Metabolomics Center, and Genome Center, University of California, Davis, Davis, CA
| | - Sean H Adams
- Obesity and Metabolism Research Unit, USDA, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA; Department of Nutrition,
| |
Collapse
|
15
|
Aguer C, McCoin CS, Knotts TA, Thrush AB, Ono-Moore K, McPherson R, Dent R, Hwang DH, Adams SH, Harper ME. Acylcarnitines: potential implications for skeletal muscle insulin resistance. FASEB J 2014; 29:336-45. [PMID: 25342132 DOI: 10.1096/fj.14-255901] [Citation(s) in RCA: 172] [Impact Index Per Article: 17.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Insulin resistance may be linked to incomplete fatty acid β-oxidation and the subsequent increase in acylcarnitine species in different tissues including skeletal muscle. It is not known if acylcarnitines participate in muscle insulin resistance or simply reflect dysregulated metabolism. The aims of this study were to determine whether acylcarnitines can elicit muscle insulin resistance and to better understand the link between incomplete muscle fatty acid β-oxidation, oxidative stress, inflammation, and insulin-resistance development. Differentiated C2C12, primary mouse, and human myotubes were treated with acylcarnitines (C4:0, C14:0, C16:0) or with palmitate with or without carnitine acyltransferase inhibition by mildronate. Treatment with C4:0, C14:0, and C16:0 acylcarnitines resulted in 20-30% decrease in insulin response at the level of Akt phosphorylation and/or glucose uptake. Mildronate reversed palmitate-induced insulin resistance concomitant with an ∼25% decrease in short-chain acylcarnitine and acetylcarnitine secretion. Although proinflammatory cytokines were not affected under these conditions, oxidative stress was increased by 2-3 times by short- or long-chain acylcarnitines. Acylcarnitine-induced oxidative stress and insulin resistance were reversed by treatment with antioxidants. Results are consistent with the conclusion that incomplete muscle fatty acid β-oxidation causes acylcarnitine accumulation and associated oxidative stress, raising the possibility that these metabolites play a role in muscle insulin resistance.
Collapse
Affiliation(s)
- Céline Aguer
- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Colin S McCoin
- Molecular, Cellular, & Integrative Physiology Graduate Program, University of California, Davis, California, USA; Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA
| | - Trina A Knotts
- Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA; Department of Nutrition, University of California, Davis, California, USA
| | - A Brianne Thrush
- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Kikumi Ono-Moore
- Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA; Department of Nutrition, University of California, Davis, California, USA
| | - Ruth McPherson
- Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
| | - Robert Dent
- Ottawa Hospital Weight Management Clinic, Ottawa, Ontario, Canada
| | - Daniel H Hwang
- Immunity & Disease Prevention Research Unit, U.S. Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA Department of Nutrition, University of California, Davis, California, USA
| | - Sean H Adams
- Molecular, Cellular, & Integrative Physiology Graduate Program, University of California, Davis, California, USA; Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA; Department of Nutrition, University of California, Davis, California, USA;
| | - Mary-Ellen Harper
- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada;
| |
Collapse
|
16
|
Rutkowsky JM, Knotts TA, Ono-Moore KD, McCoin CS, Huang S, Schneider D, Singh S, Adams SH, Hwang DH. Acylcarnitines activate proinflammatory signaling pathways. Am J Physiol Endocrinol Metab 2014; 306:E1378-87. [PMID: 24760988 PMCID: PMC4059985 DOI: 10.1152/ajpendo.00656.2013] [Citation(s) in RCA: 201] [Impact Index Per Article: 20.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Incomplete β-oxidation of fatty acids in mitochondria is a feature of insulin resistance and type 2 diabetes mellitus (T2DM). Previous studies revealed that plasma concentrations of medium- and long-chain acylcarnitines (by-products of incomplete β-oxidation) are elevated in T2DM and insulin resistance. In a previous study, we reported that mixed D,L isomers of C12- or C14-carnitine induced an NF-κB-luciferase reporter gene in RAW 264.7 cells, suggesting potential activation of proinflammatory pathways. Here, we determined whether the physiologically relevant L-acylcarnitines activate classical proinflammatory signaling pathways and if these outcomes involve pattern recognition receptor (PRR)-associated pathways. Acylcarnitines induced the expression of cyclooxygenase-2 in a chain length-dependent manner in RAW 264.7 cells. L-C14 carnitine (5-25 μM), used as a representative acylcarnitine, stimulated the expression and secretion of proinflammatory cytokines in a dose-dependent manner. Furthermore, L-C14 carnitine induced phosphorylation of JNK and ERK, common downstream components of many proinflammatory signaling pathways including PRRs. Knockdown of MyD88, a key cofactor in PRR signaling and inflammation, blunted the proinflammatory effects of acylcarnitine. While these results point to potential involvement of PRRs, L-C14 carnitine promoted IL-8 secretion from human epithelial cells (HCT-116) lacking Toll-like receptors (TLR)2 and -4, and did not activate reporter constructs in TLR overexpression cell models. Thus, acylcarnitines have the potential to activate inflammation, but the specific molecular and tissue target(s) involved remain to be identified.
Collapse
Affiliation(s)
- Jennifer M Rutkowsky
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, California
| | - Trina A Knotts
- Obesity and Metabolism Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California; Department of Nutrition, University of California, Davis, California
| | - Kikumi D Ono-Moore
- Department of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California
| | - Colin S McCoin
- Graduate Group in Molecular, Cellular and Integrative Physiology, University of California, Davis, California; and
| | - Shurong Huang
- Immunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Dina Schneider
- Immunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Shamsher Singh
- Immunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| | - Sean H Adams
- Obesity and Metabolism Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California; Department of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California; Graduate Group in Molecular, Cellular and Integrative Physiology, University of California, Davis, California; and
| | - Daniel H Hwang
- Department of Nutrition, University of California, Davis, California; Graduate Group in Nutritional Biology, University of California, Davis, California; Immunity and Disease Prevention Research Unit, US Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, Davis, California
| |
Collapse
|
17
|
Qadri I, Choudhury M, Rahman SM, Knotts TA, Janssen RC, Schaack J, Iwahashi M, Puljak L, Simon FR, Kilic G, Fitz JG, Friedman JE. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β. J Biol Chem 2012; 287:37340-51. [PMID: 22955269 DOI: 10.1074/jbc.m112.384743] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Chronic hepatitis C virus (HCV) infection greatly increases the risk for type 2 diabetes and nonalcoholic steatohepatitis; however, the pathogenic mechanisms remain incompletely understood. Here we report gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) transcription and associated transcription factors are dramatically up-regulated in Huh.8 cells, which stably express an HCV subgenome replicon. HCV increased activation of cAMP response element-binding protein (CREB), CCAAT/enhancer-binding protein (C/EBPβ), forkhead box protein O1 (FOXO1), and peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and involved activation of the cAMP response element in the PEPCK promoter. Infection with dominant-negative CREB or C/EBPβ-shRNA significantly reduced or normalized PEPCK expression, with no change in PGC-1α or FOXO1 levels. Notably, expression of HCV nonstructural component NS5A in Huh7 or primary hepatocytes stimulated PEPCK gene expression and glucose output in HepG2 cells, whereas a deletion in NS5A reduced PEPCK expression and lowered cellular lipids but was without effect on insulin resistance, as demonstrated by the inability of insulin to stimulate mobilization of a pool of insulin-responsive vesicles to the plasma membrane. HCV-replicating cells demonstrated increases in cellular lipids with insulin resistance at the level of the insulin receptor, increased insulin receptor substrate 1 (Ser-312), and decreased Akt (Ser-473) activation in response to insulin. C/EBPβ-RNAi normalized lipogenic genes sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor γ, and liver X receptor α but was unable to reduce accumulation of triglycerides in Huh.8 cells or reverse the increase in ApoB expression, suggesting a role for increased lipid retention in steatotic hepatocytes. Collectively, these data reveal an important role of NS5A, C/EBPβ, and pCREB in promoting HCV-induced gluconeogenic gene expression and suggest that increased C/EBPβ and NS5A may be essential components leading to increased gluconeogenesis associated with HCV infection.
Collapse
Affiliation(s)
- Ishtiaq Qadri
- Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011; 121:1858-70. [PMID: 21490391 PMCID: PMC3083776 DOI: 10.1172/jci43378] [Citation(s) in RCA: 500] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2010] [Accepted: 02/02/2011] [Indexed: 02/06/2023] Open
Abstract
Obesity is associated with an enhanced inflammatory response that exacerbates insulin resistance and contributes to diabetes, atherosclerosis, and cardiovascular disease. One mechanism accounting for the increased inflammation associated with obesity is activation of the innate immune signaling pathway triggered by TLR4 recognition of saturated fatty acids, an event that is essential for lipid-induced insulin resistance. Using in vitro and in vivo systems to model lipid induction of TLR4-dependent inflammatory events in rodents, we show here that TLR4 is an upstream signaling component required for saturated fatty acid-induced ceramide biosynthesis. This increase in ceramide production was associated with the upregulation of genes driving ceramide biosynthesis, an event dependent of the activity of the proinflammatory kinase IKKβ. Importantly, increased ceramide production was not required for TLR4-dependent induction of inflammatory cytokines, but it was essential for TLR4-dependent insulin resistance. These findings suggest that sphingolipids such as ceramide might be key components of the signaling networks that link lipid-induced inflammatory pathways to the antagonism of insulin action that contributes to diabetes.
Collapse
Affiliation(s)
- William L. Holland
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Benjamin T. Bikman
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Li-Ping Wang
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Guan Yuguang
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Katherine M. Sargent
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Sarada Bulchand
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Trina A. Knotts
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Guanghou Shui
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Deborah J. Clegg
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Markus R. Wenk
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Michael J. Pagliassotti
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Philipp E. Scherer
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| | - Scott A. Summers
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Program in Cardiovascular and Metabolic Diseases, Duke-National University of Singapore Graduate Medical School, Singapore.
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
United States Department of Agriculture, Agricultural Research Service Western Human Nutrition Research Center, Davis, California, USA.
Department of Biochemistry, National University of Singapore, Singapore.
Department of Nutrition, Colorado State University, Fort Collins, Colorado, USA
| |
Collapse
|
19
|
Paulino G, Barbier de la Serre C, Knotts TA, Oort PJ, Newman JW, Adams SH, Raybould HE. Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. Am J Physiol Endocrinol Metab 2009; 296:E898-903. [PMID: 19190260 PMCID: PMC2670626 DOI: 10.1152/ajpendo.90796.2008] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The vagal afferent pathway is important in short-term regulation of food intake, and decreased activation of this neural pathway with long-term ingestion of a high-fat diet may contribute to hyperphagic weight gain. We tested the hypothesis that expression of genes encoding receptors for orexigenic factors in vagal afferent neurons are increased by long-term ingestion of a high-fat diet, thus supporting orexigenic signals from the gut. Obesity-prone (DIO-P) rats fed a high-fat diet showed increased body weight and hyperleptinemia compared with low-fat diet-fed controls and high-fat diet-induced obesity-resistant (DIO-R) rats. Expression of the type I cannabinoid receptor and growth hormone secretagogue receptor 1a in the nodose ganglia was increased in DIO-P compared with low-fat diet-fed controls or DIO-R rats. Shifts in the balance between orexigenic and anorexigenic signals within the vagal afferent pathway may influence food intake and body weight gain induced by high fat diets.
Collapse
MESH Headings
- Animals
- Appetite Regulation/genetics
- Diet, Atherogenic
- Dietary Fats/pharmacology
- Male
- Nodose Ganglion/metabolism
- Obesity/etiology
- Obesity/genetics
- Obesity/metabolism
- Rats
- Rats, Sprague-Dawley
- Receptor, Cannabinoid, CB1/genetics
- Receptor, Cannabinoid, CB1/metabolism
- Receptor, Melanocortin, Type 1/genetics
- Receptor, Melanocortin, Type 1/metabolism
- Receptors, Cholecystokinin/genetics
- Receptors, Cholecystokinin/metabolism
- Up-Regulation/drug effects
- Up-Regulation/genetics
Collapse
Affiliation(s)
- Gabriel Paulino
- Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, 1321 Haring Hall, Vet Med: APC, University of California, Davis, 1 Shields Ave., Davis, CA 95616, USA
| | | | | | | | | | | | | |
Collapse
|
20
|
Thomas A, Oort PJ, Newman JW, Dunn TN, Knotts TA, Stern JS, Stanhope KL, Havel PJ, Adams SH. CD11d expression is dramatically increased in white adipose tissue of obese rodents. FASEB J 2009. [DOI: 10.1096/fasebj.23.1_supplement.221.4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Anthony Thomas
- Department of NutritionUniversity of California at DavisDavisCA
| | | | - John W. Newman
- Department of NutritionUniversity of California at DavisDavisCA
- USDA‐ARS Western Human Nutrition Research CenterDavisCA
| | - Tamara N. Dunn
- Department of NutritionUniversity of California at DavisDavisCA
| | | | - Judith S. Stern
- Department of NutritionUniversity of California at DavisDavisCA
| | | | - Peter J. Havel
- Department of NutritionUniversity of California at DavisDavisCA
| | - Sean H. Adams
- Department of NutritionUniversity of California at DavisDavisCA
- USDA‐ARS Western Human Nutrition Research CenterDavisCA
| |
Collapse
|
21
|
Oort PJ, Knotts TA, Grino M, Naour N, Bastard JP, Clément K, Ninkina N, Buchman VL, Permana PA, Luo X, Pan G, Dunn TN, Adams SH. Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity. J Nutr 2008; 138:841-8. [PMID: 18424589 PMCID: PMC3160639 DOI: 10.1093/jn/138.5.841] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 01/08/2008] [Accepted: 02/09/2008] [Indexed: 01/19/2023] Open
Abstract
Recently, we characterized tumor suppressor candidate 5 (Tusc5) as an adipocyte-neuron PPARgamma target gene. Our objective herein was to identify additional genes that display distinctly high expression in fat and neurons, because such a pattern could signal previously uncharacterized functional pathways shared in these disparate tissues. gamma-Synuclein, a marker of peripheral and select central nervous system neurons, was strongly expressed in white adipose tissue (WAT) and peripheral nervous system ganglia using bioinformatics and quantitative PCR approaches. Gamma-synuclein expression was determined during adipogenesis and in subcutaneous (SC) and visceral adipose tissue (VAT) from obese and nonobese humans. Gamma-synuclein mRNA increased from trace levels in preadipocytes to high levels in mature 3T3-L1 adipocytes and decreased approximately 50% following treatment with the PPARgamma agonist GW1929 (P < 0.01). Because gamma-synuclein limits growth arrest and is implicated in cancer progression in nonadipocytes, we suspected that expression would be increased in situations where WAT plasticity/adipocyte turnover are engaged. Consistent with this postulate, human WAT gamma-synuclein mRNA levels consistently increased in obesity and were higher in SC than in VAT; i.e. they increased approximately 1.7-fold in obese Pima Indian adipocytes (P = 0.003) and approximately 2-fold in SC and VAT of other obese cohorts relative to nonobese subjects. Expression correlated with leptin transcript levels in human SC and VAT (r = 0.887; P < 0.0001; n = 44). Gamma-synuclein protein was observed in rodent and human WAT but not in negative control liver. These results are consistent with the hypothesis that gamma-synuclein plays an important role in adipocyte physiology.
Collapse
Affiliation(s)
- Pieter J. Oort
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Trina A. Knotts
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Michel Grino
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Nadia Naour
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Jean-Phillipe Bastard
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Karine Clément
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Natalia Ninkina
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Vladimir L. Buchman
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Paska A. Permana
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Xunyi Luo
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Guohua Pan
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Tamara N. Dunn
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Sean H. Adams
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| |
Collapse
|
22
|
Paulino G, Oort PJ, Knotts TA, Adams SH, Raybould HE. Can diet influence the expression of genes associated with control of appetite? FASEB J 2008. [DOI: 10.1096/fasebj.22.1_supplement.1184.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Gabriel Paulino
- Veterinary School of MedicineDepartment of AnatomyPhysiology and Cell BiologyUCDavisUCDavisDavisCA
| | - Pieter J Oort
- Agricultural Research Service Western Human Nutrition Research CenterUCDavisUSDADavisCA
| | - Trina A. Knotts
- Agricultural Research Service Western Human Nutrition Research CenterUCDavisUSDADavisCA
| | - Sean H. Adams
- Agricultural Research Service Western Human Nutrition Research CenterUCDavisUSDADavisCA
| | - Helen E Raybould
- Veterinary School of MedicineDepartment of AnatomyPhysiology and Cell BiologyUCDavisUCDavisDavisCA
| |
Collapse
|
23
|
Oort PJ, Warden CH, Baumann TK, Knotts TA, Adams SH. Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons. Mol Cell Endocrinol 2007; 276:24-35. [PMID: 17689857 DOI: 10.1016/j.mce.2007.06.005] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2007] [Accepted: 06/22/2007] [Indexed: 12/25/2022]
Abstract
Tumor suppressor candidate 5 (Tusc5, also termed brain endothelial cell derived gene-1 or BEC-1), a CD225 domain-containing, cold-repressed gene identified during brown adipose tissue (BAT) transcriptome analyses was found to be robustly-expressed in mouse white adipose tissue (WAT) and BAT, with similarly high expression in human adipocytes. Tusc5 mRNA was markedly increased from trace levels in pre-adipocytes to significant levels in developing 3T3-L1 adipocytes, coincident with several mature adipocyte markers (phosphoenolpyruvate carboxykinase 1, GLUT4, adipsin, leptin). The Tusc5 transcript levels were increased by the peroxisome proliferator activated receptor-gamma (PPARgamma) agonist GW1929 (1microg/mL, 18h) by >10-fold (pre-adipocytes) to approximately 1.5-fold (mature adipocytes) versus controls (p<0.0001). Taken together, these results suggest an important role for Tusc5 in maturing adipocytes. Intriguingly, we discovered robust co-expression of the gene in peripheral nerves (primary somatosensory neurons). In light of the marked repression of the gene observed after cold exposure, these findings may point to participation of Tusc5 in shared adipose-nervous system functions linking environmental cues, CNS signals, and WAT-BAT physiology. Characterization of such links is important for clarifying the molecular basis for adipocyte proliferation and could have implications for understanding the biology of metabolic disease-related neuropathies.
Collapse
Affiliation(s)
- Pieter J Oort
- USDA/Agricultural Research Service Western Human Nutrition Research Center, University of California, Davis, CA 95616, USA
| | | | | | | | | |
Collapse
|
24
|
Abstract
Lipid abnormalities such as obesity, increased circulating free fatty acid levels, and excess intramyocellular lipid accumulation are frequently associated with insulin resistance. These observations have prompted investigators to speculate that the accumulation of lipids in tissues not suited for fat storage (e.g., skeletal muscle and liver) is an underlying component of insulin resistance and the metabolic syndrome. We review the metabolic fates of lipids in insulin-responsive tissues and discuss the roles of specific lipid metabolites (e.g., ceramides, GM3 ganglioside, and diacylglycerol) as antagonists of insulin signaling and action.
Collapse
Affiliation(s)
- William L Holland
- Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
| | | | | | | | | | | |
Collapse
|
25
|
|
26
|
Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5:167-79. [PMID: 17339025 DOI: 10.1016/j.cmet.2007.01.002] [Citation(s) in RCA: 922] [Impact Index Per Article: 54.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/28/2006] [Revised: 12/12/2006] [Accepted: 01/10/2007] [Indexed: 02/07/2023]
Abstract
Insulin resistance occurs in 20%-25% of the human population, and the condition is a chief component of type 2 diabetes mellitus and a risk factor for cardiovascular disease and certain forms of cancer. Herein, we demonstrate that the sphingolipid ceramide is a common molecular intermediate linking several different pathological metabolic stresses (i.e., glucocorticoids and saturated fats, but not unsaturated fats) to the induction of insulin resistance. Moreover, inhibition of ceramide synthesis markedly improves glucose tolerance and prevents the onset of frank diabetes in obese rodents. Collectively, these data have two important implications. First, they indicate that different fatty acids induce insulin resistance by distinct mechanisms discerned by their reliance on sphingolipid synthesis. Second, they identify enzymes required for ceramide synthesis as therapeutic targets for combating insulin resistance caused by nutrient excess or glucocorticoid therapy.
Collapse
Affiliation(s)
- William L Holland
- Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, Leroith D, Kahn CR, Cantley LC, Friedman JE, Draznin B. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 2005; 280:37489-94. [PMID: 16166093 DOI: 10.1074/jbc.m506967200] [Citation(s) in RCA: 101] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Insulin resistance is a cardinal feature of normal pregnancy and excess growth hormone (GH) states, but its underlying mechanism remains enigmatic. We previously found a significant increase in the p85 regulatory subunit of phosphatidylinositol kinase (PI 3-kinase) and striking decrease in IRS-1-associated PI 3-kinase activity in the skeletal muscle of transgenic animals overexpressing human placental growth hormone. Herein, using transgenic mice bearing deletions in p85alpha, p85beta, or insulin-like growth factor-1, we provide novel evidence suggesting that overexpression of p85alpha is a primary mechanism for skeletal muscle insulin resistance in response to GH. We found that the excess in total p85 was entirely accounted for by an increase in the free p85alpha-specific isoform. In mice with a liver-specific deletion in insulin-like growth factor-1, excess GH caused insulin resistance and an increase in skeletal muscle p85alpha, which was completely reversible using a GH-releasing hormone antagonist. To understand the role of p85alpha in GH-induced insulin resistance, we used mice bearing deletions of the genes coding for p85alpha or p85beta, respectively (p85alpha (+/-) and p85beta(-/-)). Wild type and p85beta(-/-) mice developed in vivo insulin resistance and demonstrated overexpression of p85alpha and reduced insulin-stimulated PI 3-kinase activity in skeletal muscle in response to GH. In contrast, p85alpha(+/-)mice retained global insulin sensitivity and PI 3-kinase activity associated with reduced p85alpha expression. These findings demonstrated the importance of increased p85alpha in mediating skeletal muscle insulin resistance in response to GH and suggested a potential role for reducing p85alpha as a therapeutic strategy for enhancing insulin sensitivity in skeletal muscle.
Collapse
Affiliation(s)
- Linda A Barbour
- Department of Medicine, University Colorado Health Sciences Center, Denver, 80262, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297-303. [PMID: 12525490 DOI: 10.1074/jbc.m212307200] [Citation(s) in RCA: 455] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Multiple studies suggest that lipid oversupply to skeletal muscle contributes to the development of insulin resistance, perhaps by promoting the accumulation of lipid metabolites capable of inhibiting signal transduction. Herein we demonstrate that exposing muscle cells to particular saturated free fatty acids (FFAs), but not mono-unsaturated FFAs, inhibits insulin stimulation of Akt/protein kinase B, a serine/threonine kinase that is a central mediator of insulin-stimulated anabolic metabolism. These saturated FFAs concomitantly induced the accumulation of ceramide and diacylglycerol, two products of fatty acyl-CoA that have been shown to accumulate in insulin-resistant tissues and to inhibit early steps in insulin signaling. Preventing de novo ceramide synthesis negated the antagonistic effect of saturated FFAs toward Akt/protein kinase B. Moreover, inducing ceramide buildup recapitulated and augmented the inhibitory effect of saturated FFAs. By contrast, diacylglycerol proved dispensable for these FFA effects. Collectively these results identify ceramide as a necessary and sufficient intermediate linking saturated fats to the inhibition of insulin signaling.
Collapse
Affiliation(s)
- Jose Antonio Chavez
- Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins 80523-1870, USA
| | | | | | | | | | | | | |
Collapse
|
29
|
Knotts TA, Orkiszewski RS, Cook RG, Edwards DP, Weigel NL. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem 2001; 276:8475-83. [PMID: 11110801 DOI: 10.1074/jbc.m009805200] [Citation(s) in RCA: 87] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
We have previously reported the identification of seven in vivo phosphorylation sites in the amino-terminal region of the human progesterone receptor (PR). From our previous in vivo studies, it was evident that several phosphopeptides remained unidentified. In particular, we wished to determine whether human PR contains a phosphorylation site in the hinge region, as do other steroid receptors including chicken PR, human androgen receptor, and mouse estrogen receptor. Previously, problematic trypsin cleavage sites hampered our ability to detect phosphorylation sites in large incomplete tryptic peptides. Using a combination of mass spectrometry and in vitro phosphorylation, we have identified six previously unidentified phosphorylation sites in human PR. Using nanoelectrospray ionization mass spectrometry, we have identified two new in vivo phosphorylation sites, Ser(20) and Ser(676), in baculovirus-expressed human PR. Ser(676) is analogous to the hinge site identified in other steroid receptors. Additionally, precursor ion scans identified another phosphopeptide that contains Ser(130)-Pro(131), a likely candidate for phosphorylation. In vitro phosphorylation of PR with Cdk2 has revealed five additional in vitro Cdk2 phosphorylation sites: Ser(25), Ser(213), Thr(430), Ser(554), and Ser(676). At least two of these, Ser(213) and Ser(676), are authentic in vivo sites. We confirmed the presence of the Cdk2-phosphorylated peptide containing Ser(213) in PR from in vivo labeled T47D cells, indicating that this is an in vivo site. Our combined studies indicate that most, if not all, of the Ser-Pro motifs in human PR are sites for phosphorylation. Taken together, these data indicate that the phosphorylation of PR is highly complex, with at least 14 phosphorylation sites.
Collapse
Affiliation(s)
- T A Knotts
- Department of Molecular and Cellular Biology, Protein Chemistry Core Laboratory, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | | | |
Collapse
|
30
|
Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 1998; 18:1369-78. [PMID: 9488452 PMCID: PMC108850 DOI: 10.1128/mcb.18.3.1369] [Citation(s) in RCA: 201] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/1997] [Accepted: 12/03/1997] [Indexed: 02/06/2023] Open
Abstract
Previously, we defined a novel class of ligands for the human progesterone receptor (PR) which function as mixed agonists. These compounds induce a conformational change upon binding the receptor that is different from those induced by agonists and antagonists. This establishes a correlation between the structure of a ligand-receptor complex and its transcriptional activity. In an attempt to define the cellular components which distinguish between different ligand-induced PR conformations, we have determined, by using a mammalian two-hybrid assay, that the nuclear receptor corepressor (NCoR) and the silencing mediator for retinoid and thyroid hormone receptor (SMRT) differentially associate with PR depending upon the class of ligand bound to the receptor. Specifically, we observed that the corepressors preferentially associate with antagonist-occupied PR and that overexpression of these corepressors suppresses the partial agonist activity of antagonist-occupied PR. Binding studies performed in vitro, however, reveal that recombinant SMRT can interact with PR in a manner which is not influenced by the nature of the bound ligand. Thus, the inability of SMRT or NCoR to interact with agonist-activated PR when assayed in vivo may relate more to the increased affinity of PR for coactivators, with a subsequent displacement of corepressors, than to an inherent low affinity for the corepressor proteins. Previous work from other groups has shown that 8-bromo-cyclic AMP (8-bromo-cAMP) can convert the PR antagonist RU486 into an agonist and, additionally, can potentiate the transcriptional activity of agonist-bound PR. In this study, we show that exogenous expression of NCoR or SMRT suppresses all 8-bromo-cAMP-mediated potentiation of PR transcriptional activity. Further analysis revealed that 8-bromo-cAMP addition decreases the association of NCoR and SMRT with PR. Thus, we propose that 8-bromo-cAMP-mediated potentiation of PR transcriptional activity is due, at least in part, to a disruption of the interaction between PR and the corepressors NCoR and SMRT. Cumulatively, these results suggest that NCoR and SMRT expression may play a pivotal role in PR pharmacology.
Collapse
Affiliation(s)
- B L Wagner
- Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA
| | | | | | | | | |
Collapse
|